Report cover image

North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmuco

Publisher Fatpos Global
Published Sep 01, 2023
Length 398 Pages
SKU # FAGL18277859

Description

North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032


North American Drug Delivery Technologies Market: By Route of Administration (Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Transmucosal Drug Delivery), By Type (Advanced, Conventional), By Application (Disease Treatment, Research/Academic Purposes), By End User (Hospitals, Home Care Settings, Ambulatory Surgical Centers/Clinics, Others), And Region – Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032

PRODUCT OVERVIEW

North American Drug Delivery Technologies Market to surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32

Drug delivery systems can be defined as the technologies that transfer drugs throughout or in the body. The delivery mechanism like a pill swallowed by patients or an injection-based vaccine is one such technology. Medicine packaging like a nanoparticle or a micelle, which prevents the drug from degrading and allows it to travel the specific body part, is another term for drug delivery systems. Earlier, doctors tried to administer therapies to the body parts that were directly affected by the sickness. Some medications can be administered locally, which minimizes side effects and drug toxicity while maximizing the effectiveness of a treatment, as opposed to systemically, which has an impact on the entire body.

MARKET HIGHLIGHTS

North American Drug Delivery Technologies Market to surpass USD 1080.8 billion by 2032 from USD 423.5 billion in 2021 at a CAGR of 8.9% in the coming years, i.e., 2022-32. Recently, a number of drug delivery systems have become more noteworthy in the North American market. The most commonly accepted method is controlled release, and it comprises dry powder inhalers, orodispersible tablets (ODT), needle-free injectors, transdermal patches, buccal transmucosal tablets, and auto and pen injectors. Drug distribution through implanted devices is also becoming more popular. These factors are expected to drive the North American Drug Delivery Technologies Market over the estimated period.

North American Drug Delivery Technologies Market Segments:
  • By Route of Administration
  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Injectable Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Topical Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery
  • By Type
  • Advanced
  • Conventional
  • By Application
  • Disease Treatment
  • Research/Academic Purposes
  • By End User
  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers/Clinics
  • Others
MARKET DYNAMICS

Growth Drivers

Growing Prevalence of Several Chronic Diseases and Innovations in the Drug Delivery Systems

Progressing Biologics Domain and Growing Competition due to the Production of Branded and Generic Drugs

Restraint

Strict Regulations by the FDA for Approval of Drugs and Medical Devices

Key Players
  • Johnson & Johnson Inc.
  • Medtronic PLC
  • 3M Company
  • Pfizer Inc
  • Becton, Dickinson and Company
  • Merck & Co. Inc.
  • Boston Scientific Corporation
  • Cipla Inc.
  • Gerresheimer AG
  • West Pharmaceutical Services Inc.
  • Other Prominent Players
(Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*

Table of Contents

398 Pages
1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. North American Drug Delivery Technologies Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 Market Characteristics
3.1. Market Definition
3.2. North American Drug Delivery Technologies Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 North American Drug Delivery Technologies Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 Macroeconomic Indicators
6 Recent Developments
7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 Risk Analysis
9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 North American Drug Delivery Technologies Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 North American Drug Delivery Technologies Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Route of Administration
11.3.1.1. Oral Drug Delivery
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Pulmonary Drug Delivery
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Injectable Drug Delivery
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Ocular Drug Delivery
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5. Nasal Drug Delivery
11.3.1.5.1. By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6. Topical Drug Delivery
11.3.1.6.1. By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7. Implantable Drug Delivery
11.3.1.7.1. By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.8. Transmucosal Drug Delivery
11.3.1.8.1. By Value (USD Million) 2022-2032F
11.3.1.8.2. Market Share (%) 2022-2032F
11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Type
11.3.2.1. Advanced
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Conventional
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By Application
11.3.3.1. Disease Treatment
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Research/Academic Purposes
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4. By End User
11.3.4.1. Hospitals
11.3.4.1.1. By Value (USD Million) 2022-2032F
11.3.4.1.2. Market Share (%) 2022-2032F
11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.2. Home Care Settings
11.3.4.2.1. By Value (USD Million) 2022-2032F
11.3.4.2.2. Market Share (%) 2022-2032F
11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.3. Ambulatory Surgical Centers/Clinics
11.3.4.3.1. By Value (USD Million) 2022-2032F
11.3.4.3.2. Market Share (%) 2022-2032F
11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.4. Others
11.3.4.4.1. By Value (USD Million) 2022-2032F
11.3.4.4.2. Market Share (%) 2022-2032F
11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F
12 United States Drug Delivery Technologies Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Route of Administration
12.3.2. By Type
12.3.3. By Application
12.3.4. By End User
13 Canada Drug Delivery Technologies Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Route of Administration
13.3.2. By Type
13.3.3. By Application
13.3.4. By End User
14 Competitive Landscape
14.1. Company market share, 2021
14.2. Key player overview
14.3. Key stakeholders
15 Company Profiles
15.1. Johnson & Johnson Inc.
15.1.1. Company Overview
15.1.2. Financial Overview
15.1.3. Key Product; Analysis
15.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
15.2. Medtronic PLC
15.3. 3M Company
15.4. Pfizer Inc
15.5. Becton, Dickinson and Company
15.6. Merck & Co. Inc.
15.7. Boston Scientific Corporation
15.8. Cipla Inc.
15.9. Gerresheimer AG
15.10. West Pharmaceutical Services Inc.
15.11. Other Prominent Players
16 Appendix
17 Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us